Expert Review of Anticancer Therapy, Volume 22, Issue 1 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Anticancer Therapy, Volume 22, Issue 1 (2022)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Volume 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
20 years of Expert Review of Anticancer Therapy
Gertjan J.L. Kaspers
Pages: 1-2
Published online: 30 Dec 2021
Citationfor20 years of Expert Review of Anticancer Therapy | Full Text | PDF (113 KB) | EPUB
  • 1045 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Article
Amivantamab for the treatment of EGFR exon 20 insertion mutant non-small cell lung cancer
Simon Vyse & Paul H Huang
Pages: 3-16
Published online: 28 Dec 2021
AbstractforAmivantamab for the treatment of EGFR exon 20 insertion mutant non-small cell lung cancer | Full Text | References | PDF (620.1 KB) | EPUB
  • 8497 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Atezolizumab, cobimetinib, and vemurafenib as first-line treatment for unresectable metastatic BRAF V600 mutated melanoma
Andreas M Schmitt, Lucy Dumas & James Larkin
Pages: 17-25
Published online: 02 Jan 2022
AbstractforAtezolizumab, cobimetinib, and vemurafenib as first-line treatment for unresectable metastatic BRAF V600 mutated melanoma | Full Text | References | PDF (322.8 KB) | EPUB
  • 514 Views
  • 4 CrossRef citations
  • 0Altmetric

Review

Surgical management of intrahepatic cholangiocarcinoma
D. Brock Hewitt, Zachary J. Brown & Timothy M Pawlik
Pages: 27-38
Published online: 15 Nov 2021
AbstractforSurgical management of intrahepatic cholangiocarcinoma | Full Text | References | PDF (1.8 MB) | EPUB
  • 2746 Views
  • 8 CrossRef citations
  • 0Altmetric
Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty
Mike Nguyen, Eva Segelov, David Goldstein, Nick Pavlakis, Jeremy Shapiro, Timothy J Price, Adnan Nagrial, Lorraine Chantrill, Trevor Leong, John Chen, Matt Burge, Christos S Karapetis, Ian Chau, Florian Lordick, Daniel Renouf, Niall Tebbutt & Amitesh C. Roy
Pages: 39-51
Published online: 23 Nov 2021
AbstractforUpdate on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty | Full Text | References | PDF (428.4 KB) | EPUB
  • 253 Views
  • 0 CrossRef citations
  • 0Altmetric
The effect of mechanical force in genitourinary malignancies
Kai Huang, Junqiang Liu, Qiwei Chen, Dan Feng, Haotian Wu, Abdullah Aldanakh, Yuli Jian, Zhongyang Xu, Shujing Wang & Deyong Yang
Pages: 53-64
Published online: 17 Nov 2021
AbstractforThe effect of mechanical force in genitourinary malignancies | Full Text | References | PDF (2.5 MB) | EPUB
  • 470 Views
  • 0 CrossRef citations
  • 0Altmetric
The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies
Fateme Sheida, Sepideh Razi, Mahsa Keshavarz-Fathi & Nima Rezaei
Pages: 65-81
Published online: 16 Dec 2021
AbstractforThe role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies | Full Text | References | PDF (1.4 MB) | EPUB
  • 736 Views
  • 5 CrossRef citations
  • 0Altmetric
Risk factors for the development of local recurrence in extremity soft-tissue sarcoma
Fabio Tirotta, Raza Sayyed, Robin L Jones & Andrew J Hayes
Pages: 83-95
Published online: 06 Dec 2021
AbstractforRisk factors for the development of local recurrence in extremity soft-tissue sarcoma | Full Text | References | PDF (1.2 MB) | EPUB
  • 216 Views
  • 3 CrossRef citations
  • 0Altmetric
The Wnt/β-catenin pathway in breast cancer therapy: a pre-clinical perspective of its targeting for clinical translation
Dezaree Raut, Amisha Vora & Lokesh Kumar Bhatt
Pages: 97-114
Published online: 30 Dec 2021
AbstractforThe Wnt/β-catenin pathway in breast cancer therapy: a pre-clinical perspective of its targeting for clinical translation | Full Text | References | PDF (3.5 MB) | EPUB
  • 425 Views
  • 1 CrossRef citations
  • 0Altmetric

Original Research

Article
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21)
Alessia Mennitto, Emma Zattarin, Massimo Di Maio, Davide Bimbatti, Ugo De Giorgi, Sebastiano Buti, Daniele Santini, Chiara Casadei, Mariella Sorarù, Carlo Messina, Claudia Mucciarini, Giuseppe Di Lorenzo, Giandomenico Roviello, Consuelo Buttigliero, Marco Stellato, Pierangela Sepe, Melanie Claps, Valentina Guadalupi, Arianna Ottini, Sandro Pignata, Filippo G. De Braud, Elena Verzoni & Giuseppe Procopio
Pages: 115-121
Published online: 29 Nov 2021
AbstractforCabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) | Full Text | References | PDF (973.2 KB) | EPUB
  • 281 Views
  • 2 CrossRef citations
  • 0Altmetric

Meta-analysis

Diagnostic accuracy of diffusion-weighted imaging in differentiating glioma recurrence from posttreatment-related changes: a meta-analysis
Xiaoli Du, Qian He, Boli Zhang, Na Li, Xuewen Zeng & Wenbo Li
Pages: 123-130
Published online: 10 Nov 2021
AbstractforDiagnostic accuracy of diffusion-weighted imaging in differentiating glioma recurrence from posttreatment-related changes: a meta-analysis | Full Text | References | PDF (2.9 MB) | EPUB | Supplemental
  • 202 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature
Genevieve S. Silva et al.
Review Article | Published online: 23 Jul 2024
Bevacizumab-containing treatment for relapsed or refractory Wilms tumor
Sarah Al-Jilaihawi et al.
Review Article | Published online: 23 Jul 2024
UNDERSTANDING the LINK BETWEEN ASPARTAME and CANCER
Morando Soffritti
Report | Published online: 23 Jul 2024
PROTACing the androgen receptor and other emerging therapeutics in prostate cancer
Peter D. Zang et al.
Review Article | Published online: 22 Jul 2024
View all latest articles